cover image: Treatments and research - FDA-approved drugs for Alzheimer's   Drugs that may delay cognitive decline

20.500.12592/khjnxj

Treatments and research - FDA-approved drugs for Alzheimer's Drugs that may delay cognitive decline

29 Jun 2021

Here is a list of questions to ask when considering an alternative treatment or supplement: Has the FDA approved this product for the treatment of Alzheimer’s or dementia symptoms? The FDA may have reviewed the data on a product, but found it to be ineffective for the intended purpose. [...] Is there independent research to support the safety and effectiveness of this product for treating Alzheimer's or other dementia? If the testing entity has a vested interest in the outcome (e.g., testing done by the company developing the product), the results may not be reliable. [...] To best serve individuals living with Alzheimer’s and their families, the Alzheimer’s Association strongly encourages makers of products that claim to be beneficial for those with Alzheimer’s or other dementia to conduct definitive clinical trials. [...] Does the developer of the product or the person recommending it to you have a potential financial gain from the use of the medication? If so, use extreme caution. [...] It is up to each manufacturer and distributer of dietary supplements to meet all safety and labeling requirements of the Dietary Supplement Health and Education Act of 1994 (DSHEA) and the FDA.

Authors

Communications One

Pages
6
Published in
United States of America